Cytokine & Growth Factor Reviews

Papers
(The median citation count of Cytokine & Growth Factor Reviews is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system986
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease805
Cytokine storm intervention in the early stages of COVID-19 pneumonia353
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons295
IL-6: Relevance for immunopathology of SARS-CoV-2220
The global impact of the coronavirus pandemic195
Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes130
SARS-CoV-2 Mutations and their Viral Variants101
The relationship between bone marrow adipose tissue and bone metabolism in postmenopausal osteoporosis91
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies87
The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved80
The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-1977
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders77
Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients70
Hallmarks of aging and immunosenescence: Connecting the dots68
The Covid-19 pandemic in Denmark: Big lessons from a small country64
A critical evaluation of glucocorticoids in the management of severe COVID-1964
Mechanisms of NLRP3 priming in inflammaging and age related diseases63
Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?59
Insulin as an immunomodulatory hormone51
Crosstalk between glucose metabolism, lactate production and immune response modulation47
Applications of the regenerative capacity of platelets in modern medicine46
Receptor binding competition: A paradigm for regulating TGF-β family action46
Semaphorins in health and disease44
Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy44
Chemokine networks modulating natural killer cell trafficking to solid tumors43
SARS-CoV-2: Targeted managements and vaccine development43
Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinoma43
ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression41
Growth differentiation factor-15 and its role in diabetes and cardiovascular disease40
Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?39
S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes38
SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities37
Biological functions and therapeutic opportunities of soluble cytokine receptors36
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?36
A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization36
Senescence in polyploid giant cancer cells: A road that leads to chemoresistance35
FGF/FGFR signaling: From lung development to respiratory diseases35
Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia34
Engineering and combining oncolytic measles virus for cancer therapy34
The RNA binding protein SRSF1 is a master switch of gene expression and regulation in the immune system33
Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease33
The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment33
Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy33
Cytokines in oncolytic virotherapy32
Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic32
The protective and pathogenic roles of CXCL17 in human health and disease: Potential in respiratory medicine32
IL-15 immunotherapy is a viable strategy for COVID-1931
An evaluation of the effects of probiotics on tumoral necrosis factor (TNF-α) signaling and gene expression31
IL-36 in chronic inflammation and cancer31
Selective inhibition of Tumor necrosis factor receptor-1 (TNFR1) for the treatment of autoimmune diseases30
Granulocyte macrophage colony-stimulating factor has come of age: From a vaccine adjuvant to antiviral immunotherapy30
Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-230
The Coronavirus pandemic – 2022: Viruses, variants & vaccines29
Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer29
Mechanisms of measles virus oncolytic immunotherapy28
The involvement of TH17 cells in the pathogenesis of IBD28
The determinant role of IL-6 in the establishment of inflammation leading to spontaneous preterm birth27
Exercise tolls the bell for key mediators of low-grade inflammation in dysmetabolic conditions26
The evolving epidemiology of monkeypox virus25
Revisiting IRF1-mediated antiviral innate immunity25
Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment25
Development of mRNA vaccines against respiratory syncytial virus (RSV)23
Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism23
Principles of the activin receptor signaling pathway and its inhibition23
Covid-19 in Brazil: A sad scenario22
Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence22
The cytokine interleukin-11 crucially links bone formation, remodeling and resorption22
Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer22
COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon21
The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy21
Multifactorial effects of hyperglycaemia, hyperinsulinemia and inflammation on bone remodelling in type 2 diabetes mellitus21
Galectins as modulators of receptor tyrosine kinases signaling in health and disease20
Crosstalk between lncRNAs in the apoptotic pathway and therapeutic targets in cancer20
The two-faces of NK cells in oncolytic virotherapy19
Macrophage-derived cytokines in pneumonia: Linking cellular immunology and genetics19
Leukemia inhibitory factor: Recent advances and implications in biotechnology19
Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?18
Cytokine storm with rapidly elevated interleukin-6 indicates sudden death in patients with critical COVID-1918
Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-1918
The expression and immunoregulation of immune checkpoint molecule VISTA in autoimmune diseases and cancers17
Small extracellular vesicle-mediated bidirectional crosstalk between neutrophils and tumor cells17
Potential effects of HMGB1 on viral replication and virus infection-induced inflammatory responses: A promising therapeutic target for virus infection-induced inflammatory diseases17
Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy17
Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron17
The pros and cons of interferons for oncolytic virotherapy17
Intracellular partners of fibroblast growth factors 1 and 2 - implications for functions17
Serum amyloid A and inflammasome activation: A link to breast cancer progression?17
Interferon, restriction factors and SUMO pathways16
Snake venom vascular endothelial growth factors (svVEGFs): Unravelling their molecular structure, functions, and research potential16
Chagas disease: Immunology of the disease at a glance16
MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets16
The pathogenic importance of CCL21 and CCR7 in rheumatoid arthritis15
B cell-activating factor and its targeted therapy in autoimmune diseases15
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review15
When Rab GTPases meet innate immune signaling pathways14
IL-6 and its role in IgA nephropathy development14
Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-1914
Revisiting PD-1/PD-L pathway in T and B cell response: Beyond immunosuppression14
Immuno-metabolic control of the balance between Th17-polarized and regulatory T-cells during HIV infection13
Netrin-1: An emerging player in inflammatory diseases13
The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment13
COVID-19 infection may increase the risk of parkinsonism – Remember the Spanish flu?13
Developing oncolytic viruses for clinical use: A consortium approach13
Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity13
Interferon regulatory factor 8 governs myeloid cell development13
Recent advances in the treatment of IBD: Targets, mechanisms and related therapies12
The IL-2A receptor pathway and its role in lymphocyte differentiation and function12
AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm12
Latest developments in tryptophan metabolism: Understanding its role in B cell immunity12
Roles of the gut microbiota in severe SARS-CoV-2 infection12
Tumour vasculature: Friend or foe of oncolytic viruses?11
Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors11
Balancing STING in antimicrobial defense and autoinflammation11
The NOTCH4-GATA4-IRG1 axis as a novel target in early-onset colorectal cancer10
Clinical progress in MSC-based therapies for the management of severe COVID-1910
Cancer and Covid-19: Collectively catastrophic10
Molecular regulation of autophagy in a pro-inflammatory tumour microenvironment: New insight into the role of serum amyloid A10
The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy10
Role of the Wnt and GTPase pathways in breast cancer tumorigenesis and treatment10
The role and transformative potential of IL-19 in atherosclerosis9
TGF-β mediated drug resistance in solid cancer9
Chemokines and chemokine receptors: Insights from human disease and experimental models of helminthiasis9
The multiple functions of the co-chaperone stress inducible protein 19
Pathogenic mechanisms of glucocorticoid-induced osteoporosis9
Oncolytic Immunotherapy: Can’t Start a Fire Without a Spark9
Extracellular vesicles as mediators of cell-cell communication in ovarian cancer and beyond – A lipids focus8
The functional roles of m6A modification in T lymphocyte responses and autoimmune diseases8
Interleukin-26 in host defense and inflammatory disorders of the airways8
Response to: Letter to the Editor on “Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcom8
Role of TGF-β signaling in the mechanisms of tamoxifen resistance8
Exosomes: Another intercellular lipometabolic communication mediators in digestive system neoplasms?8
Role of circular RNA in myocardial ischemia and ageing-related diseases8
0.068684101104736